129 related articles for article (PubMed ID: 28385150)
1. Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma.
Lee HO; Uzzo RG; Kister D; Kruger WD
J Transl Med; 2017 Apr; 15(1):72. PubMed ID: 28385150
[TBL] [Abstract][Full Text] [Related]
2. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
[TBL] [Abstract][Full Text] [Related]
3. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
4. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
5. The Significance of Pregnancy-associated Plasma Protein a Serum Concentration in Clear Cell Renal Cell Carcinoma.
Cechova M; Chocholaty M; Zima T; Babjuk M; Kalousova M
Anticancer Res; 2019 Jun; 39(6):3249-3253. PubMed ID: 31177175
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
[TBL] [Abstract][Full Text] [Related]
7. Serum amino acid levels as a biomarker for renal cell carcinoma.
Mustafa A; Gupta S; Hudes GR; Egleston BL; Uzzo RG; Kruger WD
J Urol; 2011 Oct; 186(4):1206-12. PubMed ID: 21849193
[TBL] [Abstract][Full Text] [Related]
8. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
[TBL] [Abstract][Full Text] [Related]
9. Plasma-free amino acid profiles in dogs with hepatocellular carcinoma.
Leela-Arporn R; Ohta H; Tamura M; Nagata N; Sasaoka K; Dermlim A; Nisa K; Osuga T; Morishita K; Sasaki N; Takiguchi M
J Vet Intern Med; 2019 Jul; 33(4):1653-1659. PubMed ID: 31066966
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
11. Exploring serum metabolic markers for the discrimination of ccRCC from renal angiomyolipoma by metabolomics.
Xiang M; Du F; Dai J; Chen L; Geng R; Huang H; Xie B
Biomark Med; 2020 Jun; 14(8):675-682. PubMed ID: 32613842
[No Abstract] [Full Text] [Related]
12. Perioperative dynamics and significance of amino acid profiles in patients with cancer.
Gu Y; Chen T; Fu S; Sun X; Wang L; Wang J; Lu Y; Ding S; Ruan G; Teng L; Wang M
J Transl Med; 2015 Jan; 13():35. PubMed ID: 25622826
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer.
Yadav S; Khandelwal M; Seth A; Saini AK; Dogra PN; Sharma A
Urology; 2017 Jun; 104():64-69. PubMed ID: 28336290
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
[TBL] [Abstract][Full Text] [Related]
15. Serum tissue factor as a biomarker for renal clear cell carcinoma.
Silva DD; Noronha JAP; Pinheiro da Costa BE; Zandona PCE; Carvalhal GF
Int Braz J Urol; 2018; 44(1):38-44. PubMed ID: 28727370
[TBL] [Abstract][Full Text] [Related]
16. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
17. [Serum ferritin determination: is it useful in the early diagnosis of renal carcinoma?].
D'Addessi A; Racioppi M; Zappacosta B; Fanasca A; De Michele T; Alcini E
Arch Ital Urol Androl; 1997 Dec; 69(5):283-6. PubMed ID: 9477611
[TBL] [Abstract][Full Text] [Related]
18. Kidney Injury Molecule-1 (KIM-1) in Blood Plasma of Patients with Clear-Cell Carcinoma.
Kushlinskii NE; Gershtein ES; Naberezhnov DS; Taipov MA; Bezhanova SD; Pushkar' DY; Matveev VB; Stilidi IS
Bull Exp Biol Med; 2019 Jul; 167(3):388-392. PubMed ID: 31346876
[TBL] [Abstract][Full Text] [Related]
19. iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma.
Zhang Y; Cai Y; Yu H; Li H
Biomed Res Int; 2015; 2015():802153. PubMed ID: 26425554
[TBL] [Abstract][Full Text] [Related]
20. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
